MICHAEL ENGELBERT, MD
Ophthalmology Physician · NEW YORK, NY
Individual Active NPI 1699945543
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,378 | 68,471 | $6,862,576 | $3,525,571 | $2,774,242 |
| 2023 | 1,171 | 51,334 | $4,800,518 | $3,387,372 | $2,665,059 |
| 2022 | 925 | 18,586 | $3,266,566 | $2,809,045 | $2,211,642 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 56,460 | $34 | $27 |
| 92134 | Imaging of retina | 2,890 | $48 | $37 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 2,610 | $145 | $115 |
| 92012 | Established patient problem focused exam of visual system | 1,918 | $106 | $82 |
| 92250 | Photography of the retina | 1,286 | $44 | $34 |
| 67028 | Injection of drug into eye | 1,122 | $149 | $121 |
| 92014 | Established patient complete exam of visual system | 636 | $150 | $111 |
| J0177 | Injection, aflibercept hd, 1 mg | 368 | $333 | $265 |
| 92004 | New patient complete exam of visual system | 307 | $176 | $123 |
| J0178 | Injection, aflibercept, 1 mg | 248 | $820 | $645 |
| J2778 | Injection, ranibizumab, 0.1 mg | 163 | $169 | $130 |
| 76512 | 2d ultrasound scan of eye tissue and structures | 68 | $65 | $48 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 254183-1 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New York
- NPI 1578976973
- NPI 1427639897
- NPI 1013394360
- NPI 1982655981
- NPI 1457931974
- NPI 1952397614
- NPI 1407024482
- NPI 1336454495
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.